PharmaEssentia Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 887.65 million compared to TWD 251.74 million a year ago. Net loss was TWD 735.54 million compared to TWD 540.86 million a year ago.

Basic loss per share from continuing operations was TWD 2.44 compared to TWD 1.96 a year ago.